Join the audience for a live webinar at 9 a.m. BST/10 a.m. CEST on 23 April 2024 to gain clinical insights from Maximilian Grohmann...

  New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers Active traffic at the Company’s booth...

The high-tech double-barrel nanopipette, developed by University of Leeds scientists, and applied to the global medical challenge of cancer, has - for the first...

Introducing automated tools into the treatment planning process has enabled the clinical team at the UK’s Castle Hill Hospital to improve consistency while also...

<a href="https://zephyrnet.com/wp-content/uploads/2024/03/increasing-access-to-radiotherapy-playing-the-long-game-physics-world-4.jpg" data-fancybox data-src="https://zephyrnet.com/wp-content/uploads/2024/03/increasing-access-to-radiotherapy-playing-the-long-game-physics-world-4.jpg" data-caption="Built to order Elekta’s state-of-the-art manufacturing facility in Crawley, UK, ships radiotherapy treatment systems to customers around the globe. (Courtesy:...

Join the audience for a live webinar at 3 p.m. BST/10 a.m. EDT on 10 April 2024 exploring QA for ultrahigh-dose rate FLASH radiotherapy Want...

Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditions Introduces recurring revenue model for the SRT-100 Vision™ (IG-SRT)...

BOCA RATON, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive...

Jan 26, 2024 (Nanowerk News) Scientists led by Nanyang Technological University, Singapore (NTU Singapore) have developed and simulated a new energy-efficient way to generate highly...

Ships more than 60 SRT units in 2023 To report full financial results and hold conference call on February 8th BOCA RATON, Fla. , Jan. 23,...

This year, the Physics World team selected a medical innovation as the Breakthrough of the Year: the development of a digital bridge that restores...

No dose limiting toxicities were reported in the first cohort of ultra-high concentration of nitric oxide administered at 25,000 parts per million (PPM) Phase 1...